Literature DB >> 12748248

Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.

Eric A Engels1, Stefania Pittaluga, Denise Whitby, Charles Rabkin, Yoshiyasu Aoki, Elaine S Jaffe, James J Goedert.   

Abstract

Kaposi's sarcoma-associated herpesvirus, the viral agent of Kaposi's sarcoma, is associated with two lymphoproliferative disorders: primary effusion lymphoma and multicentric Castleman's disease. To identify other lymphoproliferative conditions linked with Kaposi's sarcoma-associated herpesvirus, we studied non-Hodgkin's lymphomas arising in individuals with AIDS-associated Kaposi's sarcoma. Formalin-fixed tissues from 24 such lymphomas were examined. As expected, two primary effusion lymphomas were Kaposi's sarcoma-associated herpesvirus-positive, with immunohistochemistry demonstrating the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen in the nuclei of all neoplastic cells. Additionally, three of seven evaluable cases of the immunoblastic variant of diffuse large B-cell lymphoma (immunoblastic lymphoma) showed similar latency-associated nuclear antigen staining. These Kaposi's sarcoma-associated herpesvirus-positive immunoblastic lymphomas resembled primary effusion lymphoma histologically but were not known to involve body cavities (sites included lymph nodes, soft tissues of the neck, and spleen). Notably, 5-20% of the neoplastic cells in the Kaposi's sarcoma-associated herpesvirus-positive immunoblastic lymphomas also showed cytoplasmic staining for viral interleukin-6, a biologically active cytokine homologue found in primary effusion lymphoma. We conclude that Kaposi's sarcoma-associated herpesvirus is present in some immunoblastic lymphomas in persons with AIDS-associated Kaposi's sarcoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748248     DOI: 10.1097/01.MP.0000056629.62148.55

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  16 in total

Review 1.  NF-κB as a target for oncogenic viruses.

Authors:  Shao-Cong Sun; Ethel Cesarman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

2.  HHV8-related lymphoid proliferations: a broad spectrum of lesions from reactive lymphoid hyperplasia to overt lymphoma.

Authors:  Blanca Gonzalez-Farre; Daniel Martinez; Monica Lopez-Guerra; Marc Xipell; Ester Monclus; Jordina Rovira; Felipe Garcia; Armando Lopez-Guillermo; Luis Colomo; Elias Campo; Antonio Martinez
Journal:  Mod Pathol       Date:  2017-01-13       Impact factor: 7.842

3.  KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype.

Authors:  A Carbone; A Gloghini; E Vaccher; G Marchetti; G Gaidano; U Tirelli
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

Review 4.  Human Herpesvirus Type 8-associated Large B-cell Lymphoma: A Nonserous Extracavitary Variant of Primary Effusion Lymphoma in an HIV-infected Man: A Case Report and Review of the Literature.

Authors:  William R Foster; Alina Bischin; Russell Dorer; David M Aboulafia
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-04-01

5.  Kaposi's sarcoma-associated herpesvirus/human herpesvirus type 8-positive solid lymphomas: a tissue-based variant of primary effusion lymphoma.

Authors:  Antonino Carbone; Annunziata Gloghini; Emanuela Vaccher; Michaela Cerri; Gianluca Gaidano; Riccardo Dalla-Favera; Umberto Tirelli
Journal:  J Mol Diagn       Date:  2005-02       Impact factor: 5.568

6.  Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice.

Authors:  Priti Chugh; Hittu Matta; Sandra Schamus; Sunny Zachariah; Arvind Kumar; James A Richardson; Alice L Smith; Preet M Chaudhary
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-24       Impact factor: 11.205

7.  Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.

Authors:  Eric A Engels; Ruth M Pfeiffer; Ola Landgren; Richard D Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2010-05-01       Impact factor: 3.731

Review 8.  Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders.

Authors:  M-Q Du; C M Bacon; P G Isaacson
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

9.  Incidence and risk factors of HIV-related non-Hodgkin's lymphoma in the era of combination antiretroviral therapy: a European multicohort study.

Authors:  Julia Bohlius; Kurt Schmidlin; Dominique Costagliola; Gerd Fätkenheuer; Margaret May; Anna Maria Caro-Murillo; Amanda Mocroft; Fabrice Bonnet; Gary Clifford; Anastasia Karafoulidou; Jose M Miro; Jens Lundgren; Genevieve Chene; Matthias Egger
Journal:  Antivir Ther       Date:  2009

10.  Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers.

Authors:  Dirk P Dittmer; Kristy L Richards; Blossom Damania
Journal:  Front Microbiol       Date:  2012-04-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.